| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Miriam Olivola, Vincenzo Arienti, Nicola Bassetti, Gianluca Giovanna, Natascia Brondin. Lurasidone Augmentation of Clozapine in Refractory Schizophrenia: A Case Series. Journal of clinical psychopharmacology. 2023-02-24. PMID:36825872. |
clozapine represents the criterion standard therapy for patients with treatment-resistant schizophrenia. |
2023-02-24 |
2023-08-14 |
Not clear |
| Kathleen Hurley, Sinead O'Brien, Ciaran Halleran, Derina Byrne, Erin Foley, Jessica Cunningham, Fionnuala Hoctor, Laura J Sah. Metabolic Syndrome in Adults Receiving Clozapine; The Need for Pharmacist Support. Pharmacy (Basel, Switzerland). vol 11. issue 1. 2023-02-24. PMID:36827661. |
people who are diagnosed with treatment resistant schizophrenia (trs) are likely to have clozapine as a therapeutic management option. |
2023-02-24 |
2023-08-14 |
Not clear |
| Austin G Armstrong, Sheldon H Preskor. Thoughts on the Value of Case Series in the Literature: An Example Using the Article on Lurasidone Augmentation of Clozapine in Refractory Schizophrenia. Journal of clinical psychopharmacology. 2023-02-23. PMID:36821468. |
thoughts on the value of case series in the literature: an example using the article on lurasidone augmentation of clozapine in refractory schizophrenia. |
2023-02-23 |
2023-08-14 |
Not clear |
| Spyridon Siafis, Johannes Schneider-Thoma, Tasnim Hamza, Irene Bighelli, Shimeng Dong, Wulf-Peter Hansen, John M Davis, Georgia Salanti, Stefan Leuch. Efficacy of clozapine compared with other second-generation antipsychotic drugs in patients with treatment-resistant schizophrenia: protocol for a systematic review and individual patient data meta-analysis of randomised controlled trials. BMJ open. vol 13. issue 2. 2023-02-22. PMID:36810167. |
efficacy of clozapine compared with other second-generation antipsychotic drugs in patients with treatment-resistant schizophrenia: protocol for a systematic review and individual patient data meta-analysis of randomised controlled trials. |
2023-02-22 |
2023-08-14 |
human |
| Spyridon Siafis, Johannes Schneider-Thoma, Tasnim Hamza, Irene Bighelli, Shimeng Dong, Wulf-Peter Hansen, John M Davis, Georgia Salanti, Stefan Leuch. Efficacy of clozapine compared with other second-generation antipsychotic drugs in patients with treatment-resistant schizophrenia: protocol for a systematic review and individual patient data meta-analysis of randomised controlled trials. BMJ open. vol 13. issue 2. 2023-02-22. PMID:36810167. |
guidelines recommend clozapine for treatment-resistant schizophrenia. |
2023-02-22 |
2023-08-14 |
human |
| Caroline Fenton, Connie Kan. Clozapine is the approved option in treatment-resistant schizophrenia and requires careful management. Drugs & therapy perspectives : for rational drug selection and use. 2023-02-22. PMID:36811119. |
clozapine is the approved option in treatment-resistant schizophrenia and requires careful management. |
2023-02-22 |
2023-08-14 |
Not clear |
| Antonio F Pardiñas, Djenifer B Kappel, Milly Roberts, Francesca Tipple, Lisa M Shitomi-Jones, Adrian King, John Jansen, Marinka Helthuis, Michael J Owen, Michael C O'Donovan, James T R Walter. Pharmacokinetics and pharmacogenomics of clozapine in an ancestrally diverse sample: a longitudinal analysis and genome-wide association study using UK clinical monitoring data. The lancet. Psychiatry. vol 10. issue 3. 2023-02-21. PMID:36804072. |
the antipsychotic, clozapine, is the only licensed drug against the treatment-resistant symptoms that affect 20-30% of people with schizophrenia. |
2023-02-21 |
2023-08-14 |
Not clear |
| Suzanne Reeves, Julie Bertrand, Stephen John Obee, Samora Hunter, Robert Howard, Robert James Flanaga. A population pharmacokinetic model to guide clozapine dose selection, based on age, sex, ethnicity, body weight and smoking status. British journal of clinical pharmacology. 2023-02-16. PMID:36793249. |
guidance on clozapine dosing in treatment-resistant schizophrenia is based largely on data from white young adult males. |
2023-02-16 |
2023-08-14 |
Not clear |
| Robert James Flanagan, Samora Hunter, Stephen John Obee, Suzanne Reeve. Clozapine: Dose, Sex, Ethnicity, Smoking Habit, Age, Body Weight, and Plasma Clozapine and N-Desmethylclozapine (Norclozapine) Concentrations in Clinical Practice. Journal of clinical psychopharmacology. 2023-02-03. PMID:36735578. |
guidance on clozapine dosing in treatment refractory schizophrenia is based largely on data from young adult male white patients. |
2023-02-03 |
2023-08-14 |
Not clear |
| Yuto Masumo, Nobuhisa Kanahara, Masanobu Kogure, Fumiaki Yamasaki, Yusuke Nakata, Masaomi Iy. Dopamine supersensitivity psychosis and delay of clozapine treatment in patients with treatment-resistant schizophrenia. International clinical psychopharmacology. vol 38. issue 2. 2023-01-31. PMID:36719338. |
dopamine supersensitivity psychosis and delay of clozapine treatment in patients with treatment-resistant schizophrenia. |
2023-01-31 |
2023-08-14 |
Not clear |
| Yuto Masumo, Nobuhisa Kanahara, Masanobu Kogure, Fumiaki Yamasaki, Yusuke Nakata, Masaomi Iy. Dopamine supersensitivity psychosis and delay of clozapine treatment in patients with treatment-resistant schizophrenia. International clinical psychopharmacology. vol 38. issue 2. 2023-01-31. PMID:36719338. |
the present study retrospectively assessed dopamine supersensitivity psychosis (dsp) in addition to other measures such as age at disease onset and delay of clozapine introduction for a total of 47 treatment-resistant schizophrenia (trs) patients. |
2023-01-31 |
2023-08-14 |
Not clear |
| Srinivasan Tirupat. Ultra-Treatment-Resistant Schizophrenia and Clozapine Augmentation. Journal of clinical psychopharmacology. 2023-01-31. PMID:36719407. |
ultra-treatment-resistant schizophrenia and clozapine augmentation. |
2023-01-31 |
2023-08-14 |
Not clear |
| Erin Ellingto. Clozapine Use in Early-Onset Schizophrenia. Journal of psychosocial nursing and mental health services. vol 61. issue 2. 2023-01-31. PMID:36720054. |
clozapine use in early-onset schizophrenia. |
2023-01-31 |
2023-08-14 |
Not clear |
| Lydia Hahl-Häkkinen, Susanna Maria Rask, Anssi Solismaa, Sanna Ruuhonen, Esa Leinone. Co-medication with disulfiram markedly increased serum clozapine levels: Two case reports. Journal of psychopharmacology (Oxford, England). 2023-01-27. PMID:36703576. |
clozapine offers some benefits in treating patients with refractory schizophrenia and aud, but co-medicating with disulfiram is also common. |
2023-01-27 |
2023-08-14 |
Not clear |
| Nobuhisa Kanahara, Hiroshi Kimura, Toshihiko Kinoshita, Masaomi Iyo, Yoshiteru Takekit. Efficacy of Asenapine in Drug-resistant Psychotic Patients with Dopamine Supersensitivity Psychosis: Two Cases. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 21. issue 1. 2023-01-26. PMID:36700326. |
an antipsychotic agent with both tight binding to drd2 and a long half-life is generally effective for treating dsp, but a patient who meets the criteria of treatment-resistant schizophrenia sometimes needs treatment with clozapine. |
2023-01-26 |
2023-08-14 |
Not clear |
| Nina Treder, Albert Martínez-Pinteño, Natalia Rodríguez, Néstor Arbelo, Santiago Madero, Marta Gómez, Clemente García-Rizo, Sergi Mas, Patricia Gassó, Eduard Parellada, Constanza Moré. The Effect of Clozapine and Novel Glutamate Modulator JNJ-46356479 on Nitrosative Stress in a Postnatal Murine Ketamine Model of Schizophrenia. International journal of molecular sciences. vol 24. issue 2. 2023-01-21. PMID:36674542. |
the effect of clozapine and novel glutamate modulator jnj-46356479 on nitrosative stress in a postnatal murine ketamine model of schizophrenia. |
2023-01-21 |
2023-08-14 |
Not clear |
| Brian J Miller, Joseph P McEvoy, William V McCal. Meta-analysis of clozapine and insomnia in schizophrenia. Schizophrenia research. vol 252. 2023-01-20. PMID:36669344. |
meta-analysis of clozapine and insomnia in schizophrenia. |
2023-01-20 |
2023-08-14 |
Not clear |
| Brian J Miller, Joseph P McEvoy, William V McCal. Meta-analysis of clozapine and insomnia in schizophrenia. Schizophrenia research. vol 252. 2023-01-20. PMID:36669344. |
we performed a meta-analysis of insomnia in randomized controlled trials (rcts) of patients with schizophrenia treated with clozapine. |
2023-01-20 |
2023-08-14 |
Not clear |
| Michelle I Jakobsen, Julie P Schaug, Jimmi Nielsen, Erik Simonse. Antipsychotic prescribing practices for outpatients with schizophrenia and reasons for non-clozapine treatment - Data from a Danish quality assessment audit. Nordic journal of psychiatry. 2023-01-18. PMID:36651766. |
clozapine is the gold standard for treating treatment-resistant schizophrenia (trs) although widely underutilised. |
2023-01-18 |
2023-08-14 |
Not clear |
| Ranel Troy Santos, Sandra Mullen, Ericka L Crouse, Katie S Adam. Comparison of clozapine doses and tolerability in patients with and without concurrent valproic acid. The mental health clinician. vol 12. issue 6. 2023-01-16. PMID:36644583. |
valproic acid (vpa) and its various formulations can be given in conjunction with clozapine for seizure prophylaxis or for augmentation in schizophrenia. |
2023-01-16 |
2023-08-14 |
Not clear |